Just In
HUL shares rise 2% to ₹2,484.90 on NSE after strong profit performance
HUL's total income rose by 5% year-on-year to ₹16,715 crore in Q1FY26
HUL consolidated net profit surges 5.96% to ₹2,768 crore in Q1FY26
HUL shares rise 2% to ₹2,484.90 on NSE after strong profit performance
HUL's total income rose by 5% year-on-year to ₹16,715 crore in Q1FY26
HUL consolidated net profit surges 5.96% to ₹2,768 crore in Q1FY26

Biosimilar

(3 search results)

Biocon Biologics gets US FDA nod for Jobevne, a biosimilar for cancer treatment
Biocon developing 20 biosimilar products for global markets
Biocon wins US patent battle against Sanofi on insulin biosimilar